Sigba, Cjay .

HRN: 22-77-52  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2023
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
03/28/2023
04/03/2023
ORAL
1.5mg
Q12
Pcap C
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: